Filed under: Earnings reports, Forecasts, Pfizer (PFE), Johnson and Johnson (JNJ), Procter and Gamble (PG)

Johnson & Johnson (NYSE: JNJ), a company that counts Procter & Gamble (NYSE: PG) and Pfizer (NYSE: PFE) as colleagues, will report results for the second quarter on Tuesday, July 14. JNJ is expected to post a bit of a profit decline. Last year’s Q2, according to Earnings.com, saw the health-care business earn $1.18 per share. This time around, analysts are thinking that JNJ will do somewhere around $1.11 per share.

Will JNJ beat the analysts? It’s quite possible, since the company has a good record on this count. As a matter of fact, JNJ beat predictions by four cents back in April. Sales, however, came in a little weak. Interestingly enough, the market didn’t really care too much about the earnings performance on that day. Shares had rallied a bit in pre-market trading, but they closed slightly down by the end of the regular session. I found a similar situation back in January.

Continue reading Earnings preview: Johnson & Johnson could surprise Wall Street

Earnings preview: Johnson & Johnson could surprise Wall Street originally appeared on BloggingStocks on Mon, 13 Jul 2009 13:00:00 EST. Please see our terms for use of feeds.

Read | Read | Read | Read | Permalink | Email this | Comments

Via [bloggingstocks]

Share This

This entry was posted on Monday, July 13th, 2009 at 2:55 pm and is filed under Stocks Money News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.